Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW

Clinical trial NCT04760691 · COMPLETED

Trial details

NCT number: NCT04760691
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV Prophylaxis Transgender

Start date: 2021-03-01
Primary completion: 2025-03-24
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.